Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaume Capdevila

Showing results (61-70 of 192) with videos related to

Pageof 20
Sort By:
Advances in Therapy|November 20, 2013
Vandetanib in advanced medullary thyroid cancer: review of adverse event management strategiesEnrique Grande, Michael C Kreissl, Sebastiano Filetti, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2013
Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: a phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801)Daniel Castellano, Jaume Capdevila, Javier Sastre, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 1, 2023
Expert design thinking workshops to analyze users' perceived applicability of NUTRI-ONCOCARE algorithm to prevent and treat malnutrition in cancer patients under routine clinical practice conditions in Spain: the ALLIANCE studyEnrique Grande, Fernando Moreno, José Trigo, et al.
Frontiers in Endocrinology|December 3, 2021
Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson's Syndrome: A Case ReportOriol Mirallas, Francesca Filippi-Arriaga, Irene Hernandez Hernandez, et al.
Trials|January 16, 2024
Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NETSimron Singh, Diego Ferone, Jaume Capdevila, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 5, 2008
Pre-operative chemoradiotherapy with UFT and Leucovorin in patients with advanced rectal cancer: a phase II studyJordi Giralt, Josep Tabernero, Begoña Navalpotro, et al.
Endocrine-Related Cancer|January 31, 2012
Sorafenib in metastatic thyroid cancerJaume Capdevila, Lara Iglesias, Irene Halperin, et al.
Pancreas|December 6, 2014
Impact of prior chemotherapy use on the efficacy of everolimus in patients with advanced pancreatic neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-3 trialCatherine Lombard-Bohas, James C Yao, Timothy Hobday, et al.
Targeted Oncology|March 11, 2015
Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agentsPilar García-Alfonso, Ana Ferrer, Silvia Gil, et al.
JACC. Case Reports|April 10, 2026
Inferior Vena Cava Stenosis Mimicking Right Heart Failure in Carcinoid Heart DiseaseSofía Vila-Sanjuán, Nuria Vallejo, Gerard Martí-Aguasca, et al.
Pageof 20

Showing results (61-70 of 192) with videos related to

Sort By:
Pageof 20
Advances in Therapy|November 20, 2013
Vandetanib in advanced medullary thyroid cancer: review of adverse event management strategiesEnrique Grande, Michael C Kreissl, Sebastiano Filetti, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2013
Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: a phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801)Daniel Castellano, Jaume Capdevila, Javier Sastre, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 1, 2023
Expert design thinking workshops to analyze users' perceived applicability of NUTRI-ONCOCARE algorithm to prevent and treat malnutrition in cancer patients under routine clinical practice conditions in Spain: the ALLIANCE studyEnrique Grande, Fernando Moreno, José Trigo, et al.
Frontiers in Endocrinology|December 3, 2021
Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson's Syndrome: A Case ReportOriol Mirallas, Francesca Filippi-Arriaga, Irene Hernandez Hernandez, et al.
Trials|January 16, 2024
Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NETSimron Singh, Diego Ferone, Jaume Capdevila, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 5, 2008
Pre-operative chemoradiotherapy with UFT and Leucovorin in patients with advanced rectal cancer: a phase II studyJordi Giralt, Josep Tabernero, Begoña Navalpotro, et al.
Endocrine-Related Cancer|January 31, 2012
Sorafenib in metastatic thyroid cancerJaume Capdevila, Lara Iglesias, Irene Halperin, et al.
Pancreas|December 6, 2014
Impact of prior chemotherapy use on the efficacy of everolimus in patients with advanced pancreatic neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-3 trialCatherine Lombard-Bohas, James C Yao, Timothy Hobday, et al.
Targeted Oncology|March 11, 2015
Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agentsPilar García-Alfonso, Ana Ferrer, Silvia Gil, et al.
JACC. Case Reports|April 10, 2026
Inferior Vena Cava Stenosis Mimicking Right Heart Failure in Carcinoid Heart DiseaseSofía Vila-Sanjuán, Nuria Vallejo, Gerard Martí-Aguasca, et al.
Pageof 20